Prime Medicine (PRME) traded down -1.61 % during a 24 hours period ending at 09:19 PM Central Europe on Monday 26th. One Prime Medicine stock can currently be bought for about USD 3.61 on popular exchanges. Current supply of Prime Medicine stocks is 181.4 mn. Prime Medicine has a current market capitalization of USD 665.7 mn and approximately USD 16.7 mn worth of Prime Medicine was traded on exchanges in the last 24 hours. Since last month end, Prime Medicine has traded 19.54 % up. Simple moving average of last 200 days is at USD 3.48. The highest price of past 52 weeks was recorded at USD 5.11 on 10/28/2025. 52 weeks low was at USD 2.67 on 06/11/2026.

Here is how related stocks have performed in the past 24 hours:

  • Prospect Capital (PBB) traded down -1.32 % and now trades at USD 1.49. Current market capitalisation for Prospect Capital is USD 790.1 mn. Current price/earnings ratio for Prospect Capital is 24.92.

  • Southern Missouri (SMBC) traded up 0.18 % and now trades at USD 72.22. Current market capitalisation for Southern Missouri is USD 791.9 mn. Current price/earnings ratio for Southern Missouri is 10.53.

  • Virtus Investment (VRTS) traded down -2.48 % and now trades at USD 118.94. Current market capitalisation for Virtus Investment is USD 790.2 mn. Current price/earnings ratio for Virtus Investment is 6.83.

  • Phreesia (PHR) traded down -0.16 % and now trades at USD 12.61. Current market capitalisation for Phreesia is USD 788.3 mn. Phreesia has a current price to earnings ratio of 73.4.

  • Apnimed (APMD) traded up 2.48 % and now trades at USD 18.95. Apnimed has a market capitalisation of USD 790.6 mn. Apnimed has a current price to earnings ratio of 2.

About Prime Medicine

Prime Medicine, Inc. is a biotechnology company that specializes in developing a versatile gene editing technology to address the fundamental causes of disease by searching and replacing genes to restore normal genetic function. The company operates globally, serving customers worldwide, and its official website is www.primemedicine.com . Prime Medicine went public on the Nasdaq stock exchange on October 20th, 2022.